KEVIN RAKIN Insider Trading $ORMP ORAMED PHARMACEUTICALS INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN RAKIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN RAKIN. KEVIN RAKIN is Pres. and CEO in GENAISSANCE PHARMACEUTICALS INC ($GNSC) and President & CEO in GENAISSANCE PHARMACEUTICALS INC ($GNSC) and Director in ORAMED PHARMACEUTICALS INC. ($IGVL) and Director in HISTOGENICS CORP ($HSGX).
KEVIN RAKIN in ORAMED PHARMACEUTICALS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN RAKIN: Director
Holdings: 11,761 shares
Latest Transaction: Feb 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN RAKIN in ORAMED PHARMACEUTICALS INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNSC, HSGX, ORMP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
| Jan 14 2020 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.80 | 20,000 | 96,000 | 20,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.17 | 10,000 | 41,700 | 10,000 | |
| Sep 16 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | D | 4.17 | 10,000 | 41,700 | 0 | |
| Apr 12 2019 | ORMP | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 4.17 | 10,000 | 41,700 | 10,000 | |
| Jul 05 2017 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 7.77 | 56,773 | 441,126 | 56,773 | |
| Feb 16 2017 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Option Exercise | A | 6.23 | 5,697 | 35,492 | 5,697 | |
| Dec 07 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.59 | 3,300 | 21,763 | 15,061 | 11.8 K to 15.1 K (+28.06 %) |
| Dec 07 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.38 | 2,300 | 14,665 | 11,761 | 9.5 K to 11.8 K (+24.31 %) |
| Dec 05 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.21 | 7,261 | 45,057 | 9,461 | 2.2 K to 9.5 K (+330.05 %) |
| Dec 05 2016 | IGVL | ORAMED PHARMACEUTI ... | RAKIN KEVIN | Director | Grant | A | 6.08 | 2,200 | 13,371 | 2,200 | 0 to 2.2 K |
Page: 1